crl-peptide-aqua-gel-mask
Astressin-B peptide is a synthetic 33-amino acid peptide that has garnered significant attention for its potential applications in hair growth and managing stress-related physiological responses. Primarily recognized as a nonselective corticotropin-releasing hormone (CRH) antagonist, Astressin-B works by blocking CRH receptors (CRF1 and CRF2)2017年3月18日—"Astressin-B is a very complex peptide that isdifficult to synthesize," said Divine Skin CEO Daniel Khesin. "So we are especially excited that .... This action is crucial because CRH is a key hormone involved in the body's stress response, leading to the release of cortisol. By inhibiting CRH, Astressin-B can help reduce cortisol activity, protect neural pathways, and, importantly, support hair follicle recovery in stress-affected tissues. Research, particularly studies involving mice, has demonstrated Astressin-B's remarkable ability to reverse and prevent hair loss, suggesting its potential as a therapeutic agent for alopecia and other hair-related concerns.
The scientific exploration of Astressin-B began with its identification as a compound capable of counteracting the effects of stress on hair. Initial studies, such as those conducted at UCLA and the Salk Institute, injected Astressin-B into bald mice and observed significant hair regrowth. This breakthrough led to patent applications for its use in hair growth treatments2011年2月17日—The astressin-B peptide was responsible for the remarkable hair growth in the bald mice.Just one shot per day for five consecutive daysmaintained the effects for up to four months (16% of the 2 year lifespan of the mouse).. The peptide's mechanism involves inhibiting specific receptors that are antagonists to hair growth when the body experiences stress. This foundational research has paved the way for its incorporation into topical formulations aimed at promoting fuller, thicker, and healthier-looking hair.
Astressin-B's therapeutic potential stems from its role as a corticotropin-releasing hormone (CRH) receptor antagonist. CRH is a peptide hormone produced in the hypothalamus that plays a central role in the hypothalamic-pituitary-adrenal (HPA) axis, the body's primary stress response system. When the body perceives stress, CRH is released, stimulating the pituitary gland to release adrenocorticotropic hormone (ACTH), which in turn signals the adrenal glands to produce cortisol. Elevated cortisol levels, especially chronic exposure, can have numerous detrimental effects, including disrupting the hair growth cycle and contributing to hair loss2025年8月6日—The non-selective CRF receptors antagonist,astressin-B(5 µg/mouse) injected peripherally once a day for 5 days in 4-9 months old CRF-OE ....
Astressin-B, by acting as a nonselective antagonist for both CRF1 and CRF2 receptors, effectively intercepts this cascadeAstressin B, a Nonselective Corticotropin-Releasing Hormone .... This blockade prevents CRH from binding to its receptors, thereby reducing the downstream release of ACTH and cortisol. This reduction in stress hormones is believed to create a more favorable environment for hair follicles, promoting their recovery and stimulating new hair growth. Studies have shown that Astressin-B, when administered intraperitoneally (IP) or subcutaneously (SC), can reverse alopecia in genetically altered mice, demonstrating its efficacy in a biological model. The peptide's ability to thicken existing hair and promote regrowth has made it a subject of interest for both research institutions and cosmetic companies.
The promising research into Astressin-B's hair growth capabilities has led to its inclusion in specialized hair care products. One notable example is SpectralAstressin-B.F7, an advanced hair booster serum that incorporates Astressin-B as a key ingredient.Ds Laboratories Spectral Lotion F7 Stress Alopecia ... This formula is designed to support visibly fuller and healthier hair, addressing concerns like stress-related hair loss and general alopeciaAstressin 2B | CRF2 Receptors. The development of such products highlights the translation of scientific findings into practical applications for consumers seeking solutions for hair thinning and loss.
The synthesis of Astressin-B is described as complex, which underscores the advanced nature of the formulations that utilize it. Despite the challenges in its production, its unique properties as a peptide that counteracts stress effects on hair have made it a valuable component in cutting-edge hair careAstressin - an overview | ScienceDirect Topics. Products featuring Astressin-B aim to act as a shield for the hair, blocking the negative impacts of stress hormones and encouraging the restoration of hair follicle health. The peptide's efficacy has been maintained for significant periods in animal studies, with effects lasting up to four months after a short course of treatment.
While Astressin-B has shown considerable promise, particularly in preclinical studies and its introduction into some cosmetic products, ongoing research is essential to fully understand its long-term efficacy and safety in humans. The peptide's ability to accelerate the return to normal physiological functions after stress challenges, as observed in studies related to reproductive cycles, further broadens its potential therapeutic scope beyond hair growth. As a unique peptide candidate licensed from institutions like the Salk Institute, Astressin-B represents an exciting area of scientific inquiry. Further clinical trials and investigations will be crucial to validate its benefits and establish its place in both therapeutic and cosmetic applications. The development of more metabolically stable peptide analogs, which can eliminate natural cleavage sites through deletions or substitutions, could also enhance the therapeutic potential of Astressin-B and related compounds.What Are The Best Peptides for Hair Growth? - Concierge MD
Join the newsletter to receive news, updates, new products and freebies in your inbox.